Medication Assisted Treatment Waiver Training for APRNs as of March 31, 2017

Medication Assisted Treatment Course for Nurses - Free CE
Free, Online & With New Nursing Content!
Medication Assisted Treatment Waiver Training for Nurses
8 Hour Training + 16 Hour Training =
24 Hours of Education Required to Obtain a MAT Waiver

Register now for these 2 FREE courses on medication assisted treatment (MAT) for opioid use disorders and:

  • Complete the required 24 hours of education required to obtain a DEA waiver to prescribe MAT (including buprenorphine) for opioid use disorders.
  • Earn 24 CE contact hours, 21 of which are in pharmacology
  • Get a solid foundation in practices to decrease opioid use and opioid related deaths.
  • Explore issues you might encounter when assessing and providing MAT to persons with opioid use disorders.
  • Understand how current regulations affect your role and responsibilities as a provider.
Learn More & Register


Note that these are two standalone courses which will each come with a CE certificate. Instructions for obtaining a DEA waiver will be sent upon completion of the 24 hours of training.

 



Current Status

(May 19, 2017) Here are updates to the three aspects of the MAT waiver process for APRNs: the required 24 hours of education, the process for issuing MAT waivers, and the regulations for implementing the CARA 2016 legislation.

  • Educational Content for Required Training
    PCSS-MAT waiver training coursework has been released. Access the course here free of charge.
     
  • OMB Approval of MAT Waiver Issuance Process
    From SAMHSA Website as of February 28, 2017:

NPs and PAs who have completed the 24 hours of required training may seek to obtain a DATA 2000 waiver for up to 30 patients by completing the Waiver Notification Form. Effective February 27, 2017, SAMHSA will only accept electronic submissions of the NOI. NPs and PAs may send copies of their training certificates to infobuprenorphine@samhsa.hhs.gov or faxed them to 301-576-5237.

These waiver applications will be forwarded to the DEA, which will assign the NP or PA a special identification number. DEA regulations require this number to be included on all buprenorphine prescriptions for opioid dependency treatment, along with the NP’s or PA’s regular DEA registration number. SAMHSA shall review waiver applications within 45 days of receipt. If approved, NPs and PAs will receive a letter via email that confirms their waiver and includes their prescribing identification number.
 

  • HHS Regulation to Implement CARA 2016
    No further HHS regulation is needed before eligible NPs or PAs with a properly authorized wavier can begin prescribing buprenorphine, subject to applicable statutory patient limits.

 

The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.